Gene dosage of PMP22 is the proposed mechanism, supported by the finding that increased PMP22 protein[71] and elevated PMP22 messenger RNA (mRNA) was found in CMT1A patients in sural nerve biopsies[72]. This evidence concerns the gene PMP22 and Charcot-Marie-Tooth disease type 1A.